Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.825 USD | -10.06% | -3.67% | -59.60% |
Apr. 16 | Scilex Issues Preliminary Q1 Sales Results for ZTlido | MT |
Mar. 20 | Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.60% | 111M | |
+6.97% | 71.94B | |
-10.86% | 5.13B | |
+46.43% | 4.66B | |
+5.38% | 3.97B | |
-16.20% | 2.55B | |
+21.10% | 2.41B | |
-26.20% | 2.36B | |
+19.92% | 2.21B | |
+8.45% | 1.71B |
- Stock Market
- Equities
- SCLX Stock
- News Scilex Holding Company
- Scilex Issues Preliminary Q1 Sales Results for ZTlido